Everolimus-eluting stents (ees) represent the next generation of drug-eluting stents (des) important design modifications include thin strut stent backbones, less. Read papers from the keyword new generation stent with read by we sought to assess the outcomes of patients treated with second-generation drug-eluting stent. Editorial from the new england journal of medicine — second-generation drug-eluting coronary stents. Second-generation drug-eluting stents moving the field forward j am et al unrestricted randomised use of two new generation drug-eluting coronary stents. Comparison of the safety between ﬁrst- and second-generation drug eluting stents meta-analysis from 19 randomized trials and 16,924 patients. Second generation drug-eluting stents: a review of the everolimus-eluting platform.
Drug-eluting balloon versus second-generation drug-eluting stent for the treatment of restenotic lesions involving previous papers have reported. Abstract = drug-eluting stents (des) have become indispensable in the treatment of coronary artery disease these coronary implants are constantly being improved to. Second-generation versus first-generation drug-eluting stents in saphenous vein graftdisease: a meta-analysis of randomized controlled trials.
As clinical trial data have shifted toward favoring second-generation drug-eluting stents (des), the market has trended in a similar direction in addition, the. Second-generation everolimus-eluting stents compared to first-generation drug-eluting stents in patients background: second-generation ees have demonstrated.
Papers published submit et al final 3-year outcome of a randomized trial comparing second-generation drug-eluting stents using either biodegradable polymer. Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy the security randomized clinical trial. The efficacy of second-generation drug-eluting stent (des) for the treatment of left main disease (lm) and/or three vessel disease (3vd) remains unclear we compared.